Gina M Gehling, Keesha Powell-Roach, Diana J Wilkie, Jennifer R Dungan
{"title":"Single nucleotide polymorphisms and sickle cell disease-related pain: a systematic review.","authors":"Gina M Gehling, Keesha Powell-Roach, Diana J Wilkie, Jennifer R Dungan","doi":"10.3389/fpain.2023.1223309","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Scientists have speculated genetic variants may contribute to an individual's unique pain experience. Although research exists regarding the relationship between single nucleotide polymorphisms and sickle cell disease-related pain, this literature has not been synthesized to help inform future precision health research for sickle cell disease-related pain. Our primary aim of this systematic review was to synthesize the current state of scientific literature regarding single nucleotide polymorphisms and their association with sickle cell disease-related pain.</p><p><strong>Methods: </strong>Using the Prisma guidelines, we conducted our search between December 2021-April 2022. We searched PubMed, Web of Science, CINAHL, and Embase databases (1998-2022) and selected all peer-reviewed articles that included reports of associations between single nucleotide polymorphisms and sickle cell disease-related pain outcomes.</p><p><strong>Results: </strong>Our search yielded 215 articles, 80 of which were duplicates, and after two reviewers (GG, JD) independently screened the 135 non-duplicate articles, we retained 22 articles that met the study criteria. The synthesis of internationally generated evidence revealed that this scientific area remains predominantly exploratory in nature, with only three studies reporting sufficient power for genetic association. Sampling varied across studies with a range of children to older adults with SCD. All of the included articles (<i>n</i> = 22) examined acute pain, while only nine of those studies also examined chronic pain.</p><p><strong>Conclusion: </strong>Currently, the evidence implicating genetic variation contributing to acute and chronic sickle cell disease-related pain is characterized by modestly powered candidate-gene studies using rigorous SCD-pain outcomes. Effect sizes and directions vary across studies and are valuable for informing the design of future studies. Further research is needed to replicate these associations and extend findings with hypothesis-driven research to inform precision health research.</p>","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"4 ","pages":"1223309"},"PeriodicalIF":2.5000,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538969/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in pain research (Lausanne, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fpain.2023.1223309","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Scientists have speculated genetic variants may contribute to an individual's unique pain experience. Although research exists regarding the relationship between single nucleotide polymorphisms and sickle cell disease-related pain, this literature has not been synthesized to help inform future precision health research for sickle cell disease-related pain. Our primary aim of this systematic review was to synthesize the current state of scientific literature regarding single nucleotide polymorphisms and their association with sickle cell disease-related pain.
Methods: Using the Prisma guidelines, we conducted our search between December 2021-April 2022. We searched PubMed, Web of Science, CINAHL, and Embase databases (1998-2022) and selected all peer-reviewed articles that included reports of associations between single nucleotide polymorphisms and sickle cell disease-related pain outcomes.
Results: Our search yielded 215 articles, 80 of which were duplicates, and after two reviewers (GG, JD) independently screened the 135 non-duplicate articles, we retained 22 articles that met the study criteria. The synthesis of internationally generated evidence revealed that this scientific area remains predominantly exploratory in nature, with only three studies reporting sufficient power for genetic association. Sampling varied across studies with a range of children to older adults with SCD. All of the included articles (n = 22) examined acute pain, while only nine of those studies also examined chronic pain.
Conclusion: Currently, the evidence implicating genetic variation contributing to acute and chronic sickle cell disease-related pain is characterized by modestly powered candidate-gene studies using rigorous SCD-pain outcomes. Effect sizes and directions vary across studies and are valuable for informing the design of future studies. Further research is needed to replicate these associations and extend findings with hypothesis-driven research to inform precision health research.
背景:科学家推测,基因变异可能导致个体独特的疼痛体验。尽管有关于单核苷酸多态性与镰状细胞病相关疼痛之间关系的研究,但这些文献尚未被综合起来,以帮助为未来镰状细胞疾病相关疼痛的精确健康研究提供信息。我们这篇系统综述的主要目的是综合目前关于单核苷酸多态性及其与镰状细胞病相关疼痛的关系的科学文献。方法:使用Prisma指南,我们在2021年12月至2022年4月期间进行了搜索。我们搜索了PubMed、Web of Science、CINAHL和Embase数据库(1998-2022),并选择了所有同行评审的文章,其中包括单核苷酸多态性与镰状细胞病相关疼痛结果之间的关联报告。结果:我们的搜索产生了215篇文章,其中80篇是重复的,在两位评审员(GG,JD)独立筛选了135篇不重复的文章后,我们保留了22篇符合研究标准的文章。综合国际产生的证据表明,这一科学领域在本质上仍然主要是探索性的,只有三项研究报告了足够的基因关联能力。从儿童到老年SCD患者的研究样本各不相同。所有包含的文章(n = 22)检查了急性疼痛,而这些研究中只有9项也检查了慢性疼痛。结论:目前,通过使用严格的SCD疼痛结果进行适度有力的候选基因研究,可以证明基因变异导致急性和慢性镰状细胞病相关疼痛。效应大小和方向因研究而异,对未来研究的设计很有价值。需要进一步的研究来复制这些关联,并通过假设驱动的研究来扩展研究结果,为精确健康研究提供信息。